Faculty, Staff and Student Publications

Language

English

Publication Date

3-25-2026

Journal

Translational Psychiatry

DOI

10.1038/s41398-026-03971-1

PMID

41876492

PMCID

PMC13040068

PubMedCentral® Posted Date

3-25-2026

PubMedCentral® Full Text Version

Post-print

Abstract

The early detection of potential side effects (SEs) is a critical yet formidable challenge within the realms of drug development and patient healthcare management. Conventional in-vitro or in-vivo approaches for SE detection are often not feasible to scale during the preclinical phase for numerous drug candidates. Innovations in explainable artificial intelligence offer the prospect of early detection of potential SEs for novel therapeutics prior to their release in the market, as well as the explication of the underlying biological mechanisms. In this context, we present a novel biologically informed graph-based model, called HHAN-DSI, which capitalizes on multimodal interactions among molecular entities. Applied within the domain of the central nervous system (CNS) - the organ system associated with the largest number of SEs - our model demonstrates its capability to reveal previously unrecognized SEs of various psychiatric drugs. Moreover, HHAN-DSI elucidates the associated biological mechanisms, delineating an intricate network of genes, biological functions, drugs, and SEs.

Keywords

Humans, Neural Networks, Computer, Drug-Related Side Effects and Adverse Reactions, Central Nervous System, Psychotropic Drugs, Graph Neural Networks

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.